Alba Guglielmo

Dr. Alba Guglielmo

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
Alessandro PileriAlessandro Pileri
Alessandro Pileri
AGAlba Guglielmo
Alba Guglielmo
Vieri GrandiVieri Grandi
Vieri Grandi
SASilvia Alberti-Violetti
Silvia Alberti-Violetti
DFDaniele Fanoni
Daniele Fanoni
NPNicola Pimpinelli
Nicola Pimpinelli
Background: Mycosis fungoides (MF) and Sezary Syndrome (SS) are the most common cutaneous T-cell lymphomas. It has been hypothesized that the interaction between the immune system, cutaneous cells, and neoplastic elements may play a role in MF/SS pathogenesis and progression. Methods: This paper aims to revise in a narrative way our current knowledge of the microenvironment’s role in MF/SS. Results and Conclusions: Literature data support a possible implication of microenvironment cells in MF/SS pathogenesis and progression, opening up new therapeutic avenues.

1 March 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
Pietro QuaglinoPietro Quaglino
Pietro Quaglino
PFPaolo Fava
Paolo Fava
Alessandro PileriAlessandro Pileri
Alessandro Pileri
Vieri GrandiVieri Grandi
Vieri Grandi
MSMartina Sanlorenzo
Martina Sanlorenzo
SRSimone Ribero
Simone Ribero

13 June 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
INI. Neri
I. Neri
AGAlba Guglielmo
Alba Guglielmo
AVA. Virdi
A. Virdi
VGvaleria gaspari
valeria gaspari
MSMichela Starace
Michela Starace
Bianca Maria PiracciniBianca Maria Piraccini
Bianca Maria Piraccini
Click on the article title to read more.

13 June 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
INI. Neri
I. Neri
AVA. Virdi
A. Virdi
ICI. Corsini
I. Corsini
AGAlba Guglielmo
Alba Guglielmo
TLT. Lazzarotto
T. Lazzarotto
MLM. Lanari
M. Lanari
Background: Over the last months, during the COVID‐19 pandemic, a growing number of chilblain‐like lesions were reported mainly in children and rarely in young adults. The relationship with SARS‐CoV‐2 infection was postulated, often without any laboratory, instrumental or clinical confirmation. The disclosure of information about chilblain‐like lesions as a COVID‐19 manifestation in social media has created concern in children’s families and paediatricians.Objectives: To verify whether the chilblain‐like lesions were caused by SARS‐CoV‐2 infection.Methods: Prospective study on a case series including children who presented with acral lesions at the Pediatric Dermatology Outpatient and Pediatric Emergency Unit of the University of Bologna, from 1 April to 30 April 2020. We reported demographical, laboratory and clinical features, history of close contact with COVID‐19 patients, presence of similar skin lesions in other family members, precipitating and risk factors for chilblain onset.Results: We evaluated eight patients (five females, three males) aged between 11 and 15 years. We excluded acute or previous SARS‐CoV‐2 infection with RT‐PCR nasopharyngeal swab, serum antibody levels using chemiluminescent immunoassays. Other acute infections causing purpuric lesions at the extremities were negative in all patients. Skin lesion biopsy for histological and immunohistochemical evaluation was made in two cases and was consistent with chilblain. PCR assay on skin lesion biopsy for parvovirus B19, Mycoplasma pneumoniae and SARS‐CoV‐2 was performed in a patient and resulted negative. We identified common precipitating and risk factors: physical (cold and wet extremities, low BMI), cold and wet indoor and outdoor environment, behaviours, habits and lifestyle. We therefore reached a diagnosis of primary chilblains.Conclusions: During the COVID‐19 pandemic, a ‘cluster’ of primary chilblains developed in predisposed subjects, mainly teenagers, due to cold exposure in the lockdown period. Laboratory findings support our hypothesis, although it is also possible that an unknown infectious trigger may have contributed to the pathogenesis.

6 December 2020 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
ASAndrea Sechi
Andrea Sechi
APAnnalisa Patrizi
Annalisa Patrizi
FSFrancesco Savoia
Francesco Savoia
MLMiriam Leuzzi
Miriam Leuzzi
AGAlba Guglielmo
Alba Guglielmo
INIria Neri
Iria Neri

28 March 2024 in Cells
Verified
Journal Article
Open access
PDF file
AGAlba Guglielmo
Alba Guglielmo
CZCorrado Zengarini
Corrado Zengarini
CAClaudio Agostinelli
Claudio Agostinelli
GMGiovanna Motta
Giovanna Motta
ESElena Sabattini
Elena Sabattini
Alessandro PileriAlessandro Pileri
Alessandro Pileri
Cutaneous T cell lymphomas (CTCLs), encompassing mycosis fungoides (MF) and Sézary syndrome (SS), present a complex landscape influenced by cytokines and cellular responses. In this work, the intricate relationship between these inflammatory proteins and disease pathogenesis is examined, focusing on what is known at the clinical and therapeutic levels regarding the most well-known inflammatory mediators. An in-depth look is given to their possible alterations caused by novel immunomodulatory drugs and how they may alter disease progression. From this narrative review of the actual scientific landscape, Interferon-gamma (IFN-γ) emerges as a central player, demonstrating a dual role in both promoting and inhibiting cancer immunity, but the work navigates through all the major interleukins known in inflammatory environments. Immunotherapeutic perspectives are elucidated, highlighting the crucial role of the cutaneous microenvironment in shaping dysfunctional cell trafficking, antitumor immunity, and angiogenesis in MF, showcasing advancements in understanding and targeting the immune phenotype in CTCL. In summary, this manuscript aims to comprehensively explore the multifaceted aspects of CTCL, from the immunopathogenesis and cytokine dynamics centred around TNF-α and IFN-γ to evolving therapeutic modalities. Including all the major known and studied cytokines in this analysis broadens our understanding of the intricate interplay influencing CTCL, paving the way for improved management of this complex lymphoma.